FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989520640> ?p ?o ?g. }

• W2989520640 endingPage "175" @default.
• W2989520640 startingPage "167" @default.
• W2989520640 abstract "Abstract Aims Non-vitamin K antagonist oral anticoagulants represent a new option for prevention of embolic events in patients with atrial fibrillation (AF). However, little is known about the impact of non-cardiac comorbidities on the efficacy and safety profile of these drugs. Methods and results In a post hoc analysis of the ENGAGE AF-TIMI 48 trial, we analysed 21 105 patients with AF followed for an average of 2.8 years and randomized to either a higher-dose edoxaban regimen (HDER), a lower-dose edoxaban regimen, or warfarin. We used the updated Charlson Comorbidity Index (CCI) to stratify the patients according to the burden of concomitant disease (CCI = 0, 1, 2, 3, and ≥4). The treatment groups were then compared for safety, efficacy, and net clinical outcomes across CCI categories. There were 32.0%, 7.3%, 42.1%, 12.7%, and 6.0% of patients with CCI scores of 0, 1, 2, 3, and ≥4, respectively. A CCI score ≥4 was associated with significantly higher rates of thromboembolic events, bleeding, and death compared to CCI = 0 (P &lt; 0.05 for each). The annualized rates of the primary net clinical outcome (stroke/systemic embolism, major bleeding, or death) for CCI = 0, 1, 2, 3, or ≥4 were 5.9%, 8.7%, 6.6%, 10.3%, and 13.6% (Ptrend &lt; 0.001). There were no significant interactions between treatment with HDER vs. warfarin and efficacy, safety, and net outcomes across the CCI groups (P-interaction &gt; 0.10 for each). Conclusion Although increasing CCI scores are associated with worse outcomes, the efficacy, safety, and net clinical outcomes of edoxaban vs. warfarin were independent of the degree of comorbidity present." @default.
• W2989520640 created "2019-11-22" @default.
• W2989520640 creator A5000380712 @default.
• W2989520640 creator A5016322021 @default.
• W2989520640 creator A5019612250 @default.
• W2989520640 creator A5028866423 @default.
• W2989520640 creator A5046762339 @default.
• W2989520640 creator A5047705809 @default.
• W2989520640 creator A5050951654 @default.
• W2989520640 creator A5052211098 @default.
• W2989520640 creator A5062975805 @default.
• W2989520640 creator A5072345905 @default.
• W2989520640 creator A5078643079 @default.
• W2989520640 creator A5086836177 @default.
• W2989520640 creator A5087033748 @default.
• W2989520640 date "2019-11-05" @default.
• W2989520640 modified "2023-10-18" @default.
• W2989520640 title "Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial" @default.
• W2989520640 cites W1956185323 @default.
• W2989520640 cites W1965320794 @default.
• W2989520640 cites W1999468381 @default.
• W2989520640 cites W2000445173 @default.
• W2989520640 cites W2011936209 @default.
• W2989520640 cites W2025703615 @default.
• W2989520640 cites W2092840991 @default.
• W2989520640 cites W2096246254 @default.
• W2989520640 cites W2121656227 @default.
• W2989520640 cites W2127985968 @default.
• W2989520640 cites W2128415369 @default.
• W2989520640 cites W2132495614 @default.
• W2989520640 cites W2132505348 @default.
• W2989520640 cites W2148056560 @default.
• W2989520640 cites W2152584205 @default.
• W2989520640 cites W2152623033 @default.
• W2989520640 cites W2219896033 @default.
• W2989520640 cites W2319307002 @default.
• W2989520640 cites W2402689780 @default.
• W2989520640 cites W2435303807 @default.
• W2989520640 cites W2468578046 @default.
• W2989520640 cites W2472261290 @default.
• W2989520640 cites W2472624475 @default.
• W2989520640 cites W2507258517 @default.
• W2989520640 cites W2513537003 @default.
• W2989520640 cites W2523455750 @default.
• W2989520640 cites W2551359113 @default.
• W2989520640 cites W2609696371 @default.
• W2989520640 cites W2772633502 @default.
• W2989520640 cites W2789495441 @default.
• W2989520640 cites W2884823964 @default.
• W2989520640 cites W2887339329 @default.
• W2989520640 cites W826970266 @default.
• W2989520640 doi "https://doi.org/10.1093/ehjcvp/pvz061" @default.
• W2989520640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31687762" @default.
• W2989520640 hasPublicationYear "2019" @default.
• W2989520640 type Work @default.
• W2989520640 sameAs 2989520640 @default.
• W2989520640 citedByCount "10" @default.
• W2989520640 countsByYear W29895206402020 @default.
• W2989520640 countsByYear W29895206402021 @default.
• W2989520640 countsByYear W29895206402022 @default.
• W2989520640 countsByYear W29895206402023 @default.
• W2989520640 crossrefType "journal-article" @default.
• W2989520640 hasAuthorship W2989520640A5000380712 @default.
• W2989520640 hasAuthorship W2989520640A5016322021 @default.
• W2989520640 hasAuthorship W2989520640A5019612250 @default.
• W2989520640 hasAuthorship W2989520640A5028866423 @default.
• W2989520640 hasAuthorship W2989520640A5046762339 @default.
• W2989520640 hasAuthorship W2989520640A5047705809 @default.
• W2989520640 hasAuthorship W2989520640A5050951654 @default.
• W2989520640 hasAuthorship W2989520640A5052211098 @default.
• W2989520640 hasAuthorship W2989520640A5062975805 @default.
• W2989520640 hasAuthorship W2989520640A5072345905 @default.
• W2989520640 hasAuthorship W2989520640A5078643079 @default.
• W2989520640 hasAuthorship W2989520640A5086836177 @default.
• W2989520640 hasAuthorship W2989520640A5087033748 @default.
• W2989520640 hasConcept C126322002 @default.
• W2989520640 hasConcept C127413603 @default.
• W2989520640 hasConcept C164705383 @default.
• W2989520640 hasConcept C168563851 @default.
• W2989520640 hasConcept C2776301958 @default.
• W2989520640 hasConcept C2776704044 @default.
• W2989520640 hasConcept C2777995511 @default.
• W2989520640 hasConcept C2778810321 @default.
• W2989520640 hasConcept C2779161974 @default.
• W2989520640 hasConcept C2780290652 @default.
• W2989520640 hasConcept C2780400711 @default.
• W2989520640 hasConcept C2780645631 @default.
• W2989520640 hasConcept C2781413609 @default.
• W2989520640 hasConcept C500558357 @default.
• W2989520640 hasConcept C71924100 @default.
• W2989520640 hasConcept C78519656 @default.
• W2989520640 hasConceptScore W2989520640C126322002 @default.
• W2989520640 hasConceptScore W2989520640C127413603 @default.
• W2989520640 hasConceptScore W2989520640C164705383 @default.
• W2989520640 hasConceptScore W2989520640C168563851 @default.
• W2989520640 hasConceptScore W2989520640C2776301958 @default.
• W2989520640 hasConceptScore W2989520640C2776704044 @default.
• W2989520640 hasConceptScore W2989520640C2777995511 @default.

• next